Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna E Marneth

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood Advances|September 18, 2024
Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosisRathnam K Venkat, Robert A Redd, Amyah C Harris, et al.
Leukemia|February 26, 2026
Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicingJonas S Jutzi, Edie Crosse, Chulwoo J Kim, et al.
Haematologica|October 7, 2017
Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disordersJosé M Bastida, María L Lozano, Rocío Benito, et al.
The New England Journal of Medicine|December 12, 2013
A dominant-negative GFI1B mutation in the gray platelet syndromeDavide Monteferrario, Nikhita A Bolar, Anna E Marneth, et al.
Leukemia|February 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasmsBenjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson, et al.
Haematologica|January 19, 2019
Molecular mechanisms of bleeding disorderassociated GFI1B<sup>Q287*</sup> mutation and its affected pathways in megakaryocytes and plateletsRinske van Oorschot, Marten Hansen, Johanna M Koornneef, et al.
Science Translational Medicine|June 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccineMathieu Gigoux, Morten O Holmström, Roberta Zappasodi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood Advances|September 18, 2024
Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosisRathnam K Venkat, Robert A Redd, Amyah C Harris, et al.
Leukemia|February 26, 2026
Mutant SRSF2-associated impaired erythropoiesis is defined by increased mTORC1 signaling due to FYN missplicingJonas S Jutzi, Edie Crosse, Chulwoo J Kim, et al.
Haematologica|October 7, 2017
Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disordersJosé M Bastida, María L Lozano, Rocío Benito, et al.
The New England Journal of Medicine|December 12, 2013
A dominant-negative GFI1B mutation in the gray platelet syndromeDavide Monteferrario, Nikhita A Bolar, Anna E Marneth, et al.
Leukemia|February 24, 2026
Risk stratification of patients with TP53-mutated myeloproliferative neoplasmsBenjamin Rolles, Cilomar Martins de Oliveira Filho, Nathan Fergusson, et al.
Haematologica|January 19, 2019
Molecular mechanisms of bleeding disorderassociated GFI1B<sup>Q287*</sup> mutation and its affected pathways in megakaryocytes and plateletsRinske van Oorschot, Marten Hansen, Johanna M Koornneef, et al.
Science Translational Medicine|June 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccineMathieu Gigoux, Morten O Holmström, Roberta Zappasodi, et al.
Pageof 2